Your browser doesn't support javascript.
loading
A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults.
Baber, James; Arya, Mark; Moodley, Yuben; Jaques, Anna; Jiang, Qin; Swanson, Kena A; Cooper, David; Maddur, Mohan S; Loschko, Jakob; Gurtman, Alejandra; Jansen, Kathrin U; Gruber, William C; Dormitzer, Philip R; Schmoele-Thoma, Beate.
Afiliación
  • Baber J; Vaccine Clinical Research, Pfizer Inc, Sydney, Australia.
  • Arya M; Australian Clinical Research Network, Maroubra, Australia.
  • Moodley Y; School of Medicine, University of Western Australia, Perth, WA, Australia.
  • Jaques A; Vaccine Clinical Research, Pfizer Inc, Sydney, Australia.
  • Jiang Q; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Swanson KA; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Cooper D; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Maddur MS; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Loschko J; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Gurtman A; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Jansen KU; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Dormitzer PR; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Schmoele-Thoma B; Vaccine Research and Development, Pfizer Pharma GmbH, Berlin, Germany.
J Infect Dis ; 226(12): 2054-2063, 2022 12 13.
Article en En | MEDLINE | ID: mdl-35543281

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio / Vacunas contra Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Australia